Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Beijer Byggmaterial to acquire Bygg-Ole
Mandate

Beijer Byggmaterial to acquire Bygg-Ole

October 10, 2018 M&A

Vinge has advised Beijer Byggmaterial AB (“Beijer Byggmaterial”) in connection with Beijer Byggmaterial entering into an agreement to acquire Nacka Trä & Byggvaror, Sven Gustafsson AB ("Bygg Ole"). Completion of the transaction is subject to customary conditions.

Bygg Ole is a family owned company with stores in Nacka, Värmdö, Märsta och Saltsjö Boo. Bygg Ole has an annual turnover of more than MSEK 700 and employs more than 200 employees. Beijer Byggmaterial is Sweden’s largest wholly owned retailer and distributor of building materials with 69 stores across Sweden. With the acquisition of Bygg Ole, Beijer Byggmaterial grows to have a total of 73 stores in Sweden. Beijer Byggmaterial is part of Stark Group, the largest retailer and distributor of building materials in the Nordic region with operations in Denmark, Greenland, Norway, Sweden and Finland. 

Vinge’s team consisted of, among others, Jonas Bergström, Linda Sengul and Anna Thoms (M&A), Hayaat Ibrahim (Corporate Commercial), Kristoffer Larsson (Real Property/Lease Agreements) and Xandra Ståhlberg (Anti Trust).
 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025